Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C

Diabetes

Volumn 47, Issue 11, 1998, Pages 1676-1686

  Tsiani, Evangelia ^a,b   Bogdanovic, Elena ^a,b   Sorisky, Alexander ^c   Nagy, Laura ^d   Fantus, I George ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; PERVANADATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; VANADIC ACID;

ARTICLE; ENZYME INHIBITION; GLUCOSE TRANSPORT; HUMAN CELL; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CYTOCHALASIN D; ENZYME INHIBITORS; GENES, MYC; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN KINASE C; PROTEIN-TYROSINE-PHOSPHATASE; RATS; TRANSFECTION; VANADATES;

EID: 0031670637     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.11.1676     Document Type: Article

References (78)

1. Nechay BR: Mechanisms of action of vanadium. Ann Rev Pharmacol Toxicol 24:501-524, 1984
2. Nechay BR, Nanninga LB, Nechay PSE, Post RL, Grantham JJ, Macara IG, Kubena LF, Phillips TD, Nielsen FH: Role of vanadium in biology. Fed Proc 45:123-132, 1986
3. Cantley LC, Josephson L, Warner P, Yanagisawa M, Lechene C, Guidotti G: Vanadate is a potent (Na, K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem 252:7421-7423, 1977
4. +) ATPase from the cytoplasmic side. Nature 272:552-554, 1978
5. Swarup G, Cohen S, Garbers D: Inhibition of membrane phosphotyrosyl protein phosphatase activity by vanadate. Biochem Biophys Res Commun 107:1104-1109, 1982
6. Swarup G, Speeg JKV, Cohen S, Garbers DL: Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J Biol Chem 257:7298-7301, 1982
7. Shechter Y: Insulin-mimetic effects of vanadate: possible implications for future treatment of diabetes. Diabetes 39:1-5, 1990
8. Tsiani E, Fantus IG: Vanadium compounds: biological actions and potential as pharmacological agents. Trends Endocrinol Metab 8:51-58, 1997
9. Heyliger C, Tahiliani A, McNeil J: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227:1474-1476, 1985
10. Rossetti L, Laughlin MR: Corrections of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 84:892-899, 1989
11. Ramanadham S, Mongold J, Brownsey R, Cros G, McNeill J: Vanadyl sulfate in the treatment of diabetes mellitus in rats. Am J Physiol 257:H904-H911, 1989
12. Brichard SM, Pottier AM, Henquin JC: Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 125:2510-2516, 1989
13. Meyerovitch J, Rothenberg P, Shechter Y, Bonner-Weir S, Kahn C: Vanadate normalizes hyperglycemia m two mouse models of noninsulin-dependent diabetes mellitus. J Clin Invest 87:1286-1294, 1991
14. Brichard SM, Bailey CJ, Henquin JC: Marked improvement of glucose homeostasis in diabetic ob/ob mice given oval vanadate. Diabetes 39:1326-1332, 1990
15. Cros G, Mongold J, Serrano J, Ramanadham S, McNeill J: Effects of vanadyl derivatives on animal models of diabetes. Mol Cell Biochem 109:163-166, 1992
16. Pugazhenti S, Angel J, Khandelwal R: Long term effects of vanadate treatment on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice. Metabolism 40:941-946, 1991
17. Cohen N, Halberstam M, Shlimovich P, Chang C, Shamoon H, Rossetti L: Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 95:2501-2509, 1995
18. Goldfine A, Simonson D, Folli F, Patti M, Kahn C: In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol Cell Biochem 153:217-231, 1995
19. Kadota S, Fantus IG, Deragon G, Guyda H, Hersh B, Posner B: Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 147:259-266, 1987
20. Fantus IG, Kadota S, Deragon G, Foster B, Posner BI: Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry 28:8864-8871, 1989
21. Foot E, Bliss T, Fernandes L, Da Costa C, Leighton B: The effects of orthovanadates, vanadyl and peroxides of vanadate on glucose metabolism in skeletal muscle preparation in vitro. Mol Cell Biochem 109:157-162, 1992
22. Leighton B, Cooper G, Da Costa C, Foot E: Peroxovanadates have full insulin-like effects on glycogen synthesis in normal and insulin-resistant skeletal muscle. Biochem J 276:289-292, 1991
23. Wardzala LJ, Cushman SW, Salans LB: Mechanism of insulin action on glucose transport in the isolated rat adipose cell. Enhancement of the number of functional transport systems. J Biol Chem 253:8002-8003, 1978
24. Klip A, Ramlal T, Young DA, Holloszy JO: Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 224:224-230, 1987
25. Cheatham B, Kahn CR: Insulin action and the insulin signaling network. Endocr Rev 16:117-142, 1995
26. Fry MJ: Structure, regulation and function of phosphoinositide 3 kinases. Biochim Biophys Acta 1226:237-268, 1994
27. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M: Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J Biol Chem 269:3568-3573, 1994
28. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR: Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14:4902-1911, 1994
29. Yeh J, Gulve EA, Rameh L, Birnbaum MJ: The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 270:2107-2111, 1995
30. Tsakiridis T, McDowell HE, Walker T, Downes CP, Hundal HS, Vranic M, Klip A: Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 136:4315-4322, 1995
31. Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Dhand R, Clark AE, Holman GD, Waterfield MD, Kasuga M: 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A 91:7415-7419, 1994
32. Kotani K, Carozzi AJ, Sakaue H, Hara K, Robinson LJ, Clark SF, Yonezawa K, James DE, Kasuga M: Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochem Biophys Res Comm 209:343-348, 1995
33. Quon MJ, Chen H, Ing BL, Liu ML, Zarnowski MJ, Yonezawa K, Kasuga M, Cushman SW, Taylor SI: Roles of 1-phosphatidylinositol 3-kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells. Mol Cell Biol 15:5403-5411, 1995
34. Kotani K, Hara K, Kotani K, Yonezawa K, Kasuga M: Phosphoinositide 3-kinase as an upstream regulator of the small GTP-binding protein Rac in the insulin signaling of membrane ruffling. Biochem Biophys Res Comm 208:985-990, 1995
35. 3. J Biol Chem 269:32358-32367, 1994
36. Franke TF, Yang SI, Chan TO, Datta K, Kauzlaskas A, Morrison DK, Kaplan DR, Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736, 1995
37. Kohn AD, Kovacina KS, Roth RA: Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J 14:4288-4295, 1995
38. Mitsumoto Y, Klip A: Developmental regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem 267:4957-4962, 1992
39. Klip A, Ramlal T, Bilan PJ, Marette A, Liu Z, Mitsumoto Y: What signals are involved in the stimulation of glucose transport, by insulin in muscle cells? Cell Signal 5:519-529, 1993
40. Kimes BW, Brandt BL: Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98:367-381, 1976
41. Tsiani E, Ramlal T, Leiter L, Klip A, Fantus IG: Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide. Endocrinology 136:2505-2512, 1995
42. Ishii K, Hayashi H, Todaka M, Kamohara S, Kanai F, Jinnouchi H, Wang L, Ebina Y: Possible domains responsible for intracellular targeting and insulin-dependent translocation of glucose transporter type 4. Biochem J 309:813-823, 1995
43. Mestril R, Chi SH, Sayen MR, O'Reilly K, Dillman WH: Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against stimulation of ischemic-induced injury. J Clin Invest 93:759-767, 1994
44. 2+ or functional integrin. Biochem J 286:581-584, 1992
45. Alessi DR, Caudwell FB, Andjelkovic M, Hemmings BA, Cohen P: Molecular basis for the substrate specificity of protein kinase B, comparison with MAP-KAP kinase-1 and p70 S6 kinase. FEBS Lett 399:333-338, 1996
46. Tsiani E, Abdullah N, Fantus IG: The insulin-mimetic agents vanadate and pervanadate stimulate glucose but inhibit amino acid uptake. Am J Physiol 272:C156-C162, 1997
47. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA: Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15:6541-6551, 1996
48. Marte BM, Dounward J: PKB/AKT: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22:355-358, 1997
49. Kohn AD, Summers SA, Birnbaum MJ, Roth RA: Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271:31372-31378, 1996
50. Tanti JF, Grillo S, Gremeaux T, Coffer PJ, Van Obberghen E, Le Marchand-Brustel Y: Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 138:2005-2010, 1997
51. Ueki K, Yamamoto-Honda R, Kaburagi Y, Yamauchi T, Tobe K, Burgering BMTH, Coffer PJ, Komuro I, Akanuma Y, Yazaki Y, Kadowaki T: Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273:5315-5322, 1998
52. Konishi H, Matsuzaki H, Tanaka M, Ono Y, Tokunaga C, Kuroda S, Kikkawa U: Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 93:7639-7643, 1996
53. Moule SK, Welsh GI, Edgell NJ, Foulstone EJ, Proud CG, Denton RM: Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and β-adrenergic agonists in rat epididymal fat cells. J Biol Chem 272:7713-7719, 1997
54. Henriksen EJ, Rodnick KJ, Holloszy JO: Activation of glucose transport in skeletal muscle by phospholipase C and phorbol ester. J Biol Chem 264:21536-21543, 1989
55. Cooper DR, Vila MC, Watson J, Nair G, Pollet RJ, Standaert M, Farese RV: Sulfonylurea-stimulatecl glucose transport associated with diacylglycerol like activation of protein kinase C in BC3H1 myocytes. Diabetes 39:1399-1407, 1990
56. Tsakiridis T, Vranic M, Klip A: Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem 269:29934-29942, 1994
57. Hadari Y, Tzahar E. Navid O, Rothenberg P, Roberts CT Jr, LeRoith D, Yarden Y, Zick V: Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3-kinase upon its association with pp185 (IRS-1) in intact rat livers. J Biol Chem 267:17483-17486, 1992
58. Wilden PA, Broadway D: Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphotidylinositol 3, MAP, and S6 kinase activities. J Cell Physiol 16:3:9-18, 1995
59. Paquet MR, Romanek RJ, Sargeant RJ: Vanadate induces the recruitment of GLUT-4 glucose transport to the plasma membrane of rat adipocytes. Mol Cell Biochem 109:149-155, 1992
60. Andjelkovic M, Jakubowicz T, Cron P, Ming X-F, Man J-W, Hemmings BA: Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci U S A 93:5699-5704, 1996
61. Yu B, Standaert M, Arnold T, Hernandez H, Watson J, Ways K, Cooper DR, Farese RV: Effects of insulin on diacylglycerol/protein kinase-C signaling and glucose transport in rat skeletal muscles in vivo and in vitro. Endocrinology 130:3345-3355, 1992
62. Ishizuka T, Cooper DR, Hernandez H, Buckley D, Standaert M, Farese RV: Effects of insulin on diacylglycerol-protein kinase C signaling in rat diaphragm and soleus muscles and relationships to glucose transport. Diabetes 39:181-190, 1990
63. Carpenter G: Receptor tyrosine kinase substrates: Src homology domains and signal transduction. FASEB J 6:3283-3289, 1992
64. Pumiglia KM, Lau LF, Huang CK, Burroughs S, Feinstein MB: Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Biochem J 7286:441-449, 1992
65. Atkinson TP, Lee CW, Rhee SG, Hohman RJ: Orthovanadate induces translocation of phospholipase C-gamma 1 and -gamma 2 in permeabilized mast cells. J Immunol 151:1448-1455, 1993
66. Blake RA, Walker TR, Watson SP: Activation of human platelets by peroxovanadate is associated with tyrosine phosphorylation of phospholipase C gamma and formation of inositol phosphates. Biochem J 290:471-475, 1993
67. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH, Mushinski JF: Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology anchorage dependence, and tumorigenicity. J Biol Chem 268:6090-6096, 1993
68. Bandyopadhyay G, Standaert ML, Zhao L, Yu B, Avignon A, Galloway L. Karnam P, Moscat J, Farese RY: Activation of protein kinase C (α, β, and Ζ) by insulin in 3T3/11 cells. Transfection studies suggest a role for PKC- ζ in glucose transport. J Biol Chem 272:2551-2558, 1997
69. Berger J, Hayes N, Szalkowski DM, Zhang B: PI 3-kinase activation is required for insulin stimulation of glucose transport into L6 myotubes. Biochem Biophys Res Comm 205:570-576, 1994
70. Ida M, Imai K, Hashimoto S, Kawashima H: Pervanadate stimulation of wortmannin-sensitive and -resistant 2-deoxyglucose transport in adipocytes. Biochem Pharmacol 51:1061-1067, 1996
71. Shisheva A, Shechter Y: Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes. J Biol Chem 268:6463-6469, 1993
72. Elberg G, He Z, Li J, Sekar N, Shechter Y: Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes. Diabetes 46:1684-1690, 1997
73. Rondinone CM, Smith U: Okadaic acid exerts a full insulin-like effect on glucose transport and glucose transporter 4 translocation in human adipocytes: evidence for a phosphatidylinositol 3-kinase-independent pathway. J Biol Chem 271:18148-18153, 1996
74. Sakaue H, Ogawa W, Takata M, Kuroda S, Kotani K, Matsumoto M, Sakaue M, Nishio S, Ueno H, Kasuga M: Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 11:1552-1562, 1997
75. Chen D, Elmendorf JS, Olson AL, Li X, Earp HS, Pessin JE: Osmotic shock stimulates GLUT4 translocation in 3T3L1 adipocytes by a novel tyrosine kinase pathway. J Biol Chem 272:27401-27410, 1997
76. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556, 1993
77. Fauman EB, Saper MA: Structure and function of the protein tyrosine phosphatases. Trends Biochem Sci 21:413-417, 1996
78. D'Onofrio F, Le MQ, Chiasson J-L, Srivastava AK: Activation of mitogen-activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylation. FEBS Lett 340:269-275, 1994